Anti-proliferative effects of phosphodiester oligodeoxynucleotides

• The immunostimulatory effects of cytosine-phosphate-guanosine (CpG)-containing oligodeoxynucleotides (ODNs) have been extensively documented. In this paper, we describe the inhibitory effects of ODNs that contain natural phosphodiester backbones (O-ODNs) on the immunostimulation caused by CpG-containing phosphorothioated ODNs (CpG-S). CpG-S stimulation of mouse splenocyte proliferation was reduced by the addition of O-ODNs that contained or lacked the CpG-motif (CpG-containing phosphodiester oligodeoxynucleotide, CpG-O or GpC-O). The total number of cultured splenocytes was up-regulated by CpG-S, whereas repetitive addition of O-ODNs to the cell cultures inhibited this effect. The frequency of T2-like B cells was found to be increased by CpG-S. The culture supernatants of CpG-S-treated splenocytes contained elevated levels of IL-10 and IL-6. However, IL-10 and IL-6 production was down-regulated significantly by the combination of CpG-S and either CpG-O or GpC-O. The O-ODN mediated inhibition of proliferation was less pronounced in IL-10-/- mice. Thus, the O-ODNs, irrespective of CpG content, exerted inhibitory activities on the proliferation of B cells. These anti-proliferative effects appear to be mediated both by the down-regulation of IL-10 production and increased apoptosis.

Nyckelord

Adjuvants

Immunologic/*pharmacology

Animals

Apoptosis

B-Lymphocytes/*drug effects

Cell Proliferation/drug effects

Cells

Cultured

Deoxyribonuclease I/deficiency/genetics

Down-Regulation

Female

Interleukin-10/metabolism

Interleukin-6/metabolism

Mice

Mice

Inbred Strains

NF-kappa B/metabolism

Oligodeoxyribonucleotides/*pharmacology

Spleen/cytology

Thionucleotides/*pharmacology

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)